Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-2-19
pubmed:databankReference
pubmed:abstractText
To compare the efficacy of etoricoxib 30 mg with the generally maximum recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two identically designed studies.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1462-0324
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
496-507
pubmed:dateRevised
2008-12-4
pubmed:meshHeading
pubmed-meshheading:16936327-Adult, pubmed-meshheading:16936327-Aged, pubmed-meshheading:16936327-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16936327-Blood Pressure, pubmed-meshheading:16936327-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:16936327-Double-Blind Method, pubmed-meshheading:16936327-Female, pubmed-meshheading:16936327-Follow-Up Studies, pubmed-meshheading:16936327-Gastrointestinal Diseases, pubmed-meshheading:16936327-Humans, pubmed-meshheading:16936327-Male, pubmed-meshheading:16936327-Middle Aged, pubmed-meshheading:16936327-Osteoarthritis, pubmed-meshheading:16936327-Osteoarthritis, Hip, pubmed-meshheading:16936327-Osteoarthritis, Knee, pubmed-meshheading:16936327-Pyrazoles, pubmed-meshheading:16936327-Pyridines, pubmed-meshheading:16936327-Severity of Illness Index, pubmed-meshheading:16936327-Sulfonamides, pubmed-meshheading:16936327-Sulfones, pubmed-meshheading:16936327-Thrombosis, pubmed-meshheading:16936327-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
pubmed:affiliation
Johns Hopkins University Baltimore, MD, USA. Clifton.bingham@jhmi.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study